ZURN ELKAY WATER SOLUTIONS CORPORATION (ZWS) capitalization

Current snapshot

Market Cap
$7.48B
166.9M shares × $44.84 · as of last filing 2026-03-31
Net Worth
$1.61B
Stockholders' equity · 2026-03-31
Enterprise Value
$7.77B
Market cap + debt − cash
Net Debt
$288.2M
Debt $561.7M − Cash $273.5M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $7.96B
FY'24 2024-12-31 $6.51B
FY'23 2023-12-31 $5.21B
FY'22 2022-12-31 $3.25B
FY'21 2021-12-31 $4.55B
FY'20 2020-12-31 $2.35B
FY'20 2020-03-31 $1.25B
FY'19 2019-03-31 $1.49B
FY'18 2018-03-31 $1.74B
FY'17 2017-03-31 $1.16B
FY'16 2016-03-31 $1.01B
FY'13 2015-03-31 $1.35B
FY'13 2014-03-31 $1.41B
FY'12 2013-03-31 $1.02B
FY'11 2012-03-31 $732.5M
FY'11 2011-03-31
FY'11 2010-03-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $7.61B
Q4'25 2025-12-31 $7.76B
Q3'25 2025-09-30 $8.01B
Q2'25 2025-06-30 $6.22B
Q1'25 2025-03-31 $5.68B
Q4'24 2024-12-31 $6.35B
Q3'24 2024-09-30 $6.22B
Q2'24 2024-06-30 $5.15B
Q1'24 2024-03-31 $5.88B
Q4'23 2023-12-31 $5.07B
Q3'23 2023-09-30 $4.94B
Q2'23 2023-06-30 $4.75B
Q1'23 2023-03-31 $3.81B
Q4'22 2022-12-31 $3.74B
Q3'22 2022-09-30 $4.28B
Q2'22 2022-06-30 $3.50B
Q1'22 2022-03-31 $4.55B
Q4'21 2021-12-31 $4.58B
Q3'21 2021-09-30 $3.87B
Q2'21 2021-06-30 $3.00B
Q1'21 2021-03-31 $2.80B
Q4'20 2020-12-31 $2.27B
Q3'20 2020-09-30 $1.76B
Q2'20 2020-06-30 $1.71B
Q4'20 2020-03-31 $1.31B
Q3'20 2019-12-31 $1.94B
Q2'20 2019-09-30 $1.61B
Q1'20 2019-06-30 $1.80B
Q4'19 2019-03-31 $1.27B
Q3'19 2018-12-31 $1.36B
Q2'19 2018-09-30 $1.83B
Q1'19 2018-06-30 $1.50B
Q4'18 2018-03-31 $1.49B
Q3'18 2017-12-31 $1.53B
Q2'18 2017-09-30 $1.29B
Q1'18 2017-06-30 $1.18B
Q4'17 2017-03-31 $1.15B
Q3'17 2016-12-31 $986.7M
Q2'17 2016-09-30 $1.08B
Q1'17 2016-06-30 $985.1M
Q4'16 2016-03-31 $988.0M
Q3'16 2015-12-31 $897.1M
Q2'16 2015-09-30 $841.5M
Q1'16 2015-06-30 $1.20B
Q4'13 2015-03-31 $1.32B
Q3'15 2014-12-31 $1.42B
Q2'15 2014-09-30 $1.43B
Q1'15 2014-06-30 $1.42B
Q4'13 2014-03-31 $1.41B
Q3'13 2013-12-28 $1.30B
Q2'13 2013-09-28 $978.8M
Q1'13 2013-06-29 $815.1M
Q4'12 2013-03-31 $994.1M
Q3'12 2012-12-29 $1.01B
Q2'12 2012-09-29 $875.4M
Q1'12 2012-06-30 $908.4M
Q4'11 2012-03-31 $688.5M
Q3'12 2011-12-31
Q2'12 2011-10-01
Q1'12 2011-07-02
Q4'11 2011-03-31

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (ZWS CIK 0001439288), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

INDV

Indivior Pharmaceuticals, Inc.

SATS

EchoStar Corporation

BIO

Bio-Rad Laboratories, Inc.